LLY
Eli Lilly and Company
$1,443.50+16.22 (+1.14%)Close Nov 13, 2026
Insider trading
12 months to Nov 10, 2026- Sold
- $77.6B
- 5 insiders
- Largest seller
- $77.6B
- Lilly Endowment · 100% of sales
- Plan sales
- $26.9M
- 0% of sales
- Latest buy
- Aug 15, 2025
- Lucas Montarce
Buys and sales on the price
Since 2003By period
Open-market trades| Trades | 3 months | 12 months | Since 2003 |
|---|---|---|---|
| Buys | 0 | 0 | 30 |
| Sales | 2 | 24 | 968 |
| Plan sales | 2 | 6 | 151 |
| Shares bought | 00 | 00 | 95,83995.8K |
| Shares sold | 11,50011.5K | 1,835,9591.84M | 66,739,35566.7M |
| Net shares | −11,500−11.5K | −1,835,959−1.84M | −66,643,516−66.6M |
| Net value | −$14.7M | −$77.6B | −$112B |
Insiders
| Insider | 12 months | Shares held |
|---|---|---|
David A. Ricks President, Chair, and CEO, Director | — | 685,273 |
Daniel Skovronsky EVP, Cs&po & Pres. LRL | — | 235,569 |
J. Erik Fyrwald Director | — | 75,544 |
Ralph Alvarez Director | — | 56,606 |
Patrik Jonsson EVP & President, LLY Int'l | −12.0% | 54,075 |
Trades
998 trades since 2003| Type | Insider | Role | Shares | Price | Held after | |||
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Plan sale | Anat HakimEVP, GC & Secretary EVP, GC & Secretary | EVP, GC & Secretary | 5,000 at $1,402.52 | $1,402.52 | $7.01M | −9.9% 45.6K after | 45,562 |
| Aug 17, 2026 | Plan sale | Patrik JonssonEVP & President, LLY Int'l EVP & President, LLY Int'l | EVP & President, LLY Int'l | 6,500 at $1,175.10 | $1,175.10 | $7.64M | −10.6% 54.8K after | 54,779 |
| Aug 10, 2026 | Plan sale | Donald A. ZakrowskiSVP, Finance, & CAO SVP, Finance, & CAO | SVP, Finance, & CAO | 2,000 at $1,185.01 | $1,185.01 | $2.37M | −38.0% 3.26K after | 3,261 |
| Aug 7, 2026 | Plan sale | Anat HakimEVP, GC & Secretary EVP, GC & Secretary | EVP, GC & Secretary | 5,000 at $1,190.00 | $1,190.00 | $5.95M | −9.0% 50.6K after | 50,562 |
| Jun 10, 2026 | Plan sale | Ilya YuffaEVP&Pres, LLY USA&Global Capab EVP&Pres, LLY USA&Global Capab | EVP&Pres, LLY USA&Global Capab | 2,500 at $1,150.77 | $1,150.77 | $2.88M | −7.7% 29.8K after | 29,804 |
| May 6, 2026 | Sale | Lilly EndowmentFormer 10% Shareholder Former 10% Shareholder | Former 10% Shareholder | 15,828 at $995.36 | $995.36 | $15.8M | −<0.1% 91.9M after | 91,881,150 |
| Jan 7, 2026 | Sale | Lilly Endowment10% owner 10% owner | 10% owner | 292,148 at $1,103.48 | $1,103.48 | $322M | −0.3% 91.9M after | 91,896,978 |
| Jan 5, 2026 | Sale | Lilly Endowment10% owner 10% owner | 10% owner | 1,390 at $1,085.01 | $1,085.01 | $1.51M | −<0.1% 92.2M after | 92,189,126 |
| Dec 29, 2025 | Sale | Lilly Endowment10% owner 10% owner | 10% owner | 3,593 at $1,085.04 | $1,085.04 | $3.90M | −<0.1% 92.2M after | 92,190,516 |
| Dec 24, 2025 | Sale | Lilly Endowment10% owner 10% owner | 10% owner | 2,629 at $1,085.17 | $1,085.17 | $2.85M | −<0.1% 92.2M after | 92,194,109 |
- Anat Hakim$7.01MNov 2, 2026 · Plan sale5,000 at $1,402.52EVP, GC & Secretary−9.9% of holdings, 45.6K after
- Patrik Jonsson$7.64MAug 17, 2026 · Plan sale6,500 at $1,175.10EVP & President, LLY Int'l−10.6% of holdings, 54.8K after
- Donald A. Zakrowski$2.37MAug 10, 2026 · Plan sale2,000 at $1,185.01SVP, Finance, & CAO−38.0% of holdings, 3.26K after
- Anat Hakim$5.95MAug 7, 2026 · Plan sale5,000 at $1,190.00EVP, GC & Secretary−9.0% of holdings, 50.6K after
- Ilya Yuffa$2.88MJun 10, 2026 · Plan sale2,500 at $1,150.77EVP&Pres, LLY USA&Global Capab−7.7% of holdings, 29.8K after
- Lilly Endowment$15.8MMay 6, 2026 · Sale15,828 at $995.36Former 10% Shareholder−<0.1% of holdings, 91.9M after
- Lilly Endowment$322MJan 7, 2026 · Sale292,148 at $1,103.4810% owner−0.3% of holdings, 91.9M after
- Lilly Endowment$1.51MJan 5, 2026 · Sale1,390 at $1,085.0110% owner−<0.1% of holdings, 92.2M after
- Lilly Endowment$3.90MDec 29, 2025 · Sale3,593 at $1,085.0410% owner−<0.1% of holdings, 92.2M after
- Lilly Endowment$2.85MDec 24, 2025 · Sale2,629 at $1,085.1710% owner−<0.1% of holdings, 92.2M after